Arenicin-1 vs Insulin Glargine
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Insulin Glargine (Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Insulin Glargine |
|---|---|---|
| Category | Marine-Derived | Diabetes & Metabolic |
| Full Name | Arenicin-1 | Insulin glargine (A21Gly,B31Arg,B32Arg human insulin analog) |
| Molecular Weight | 2079 Da | 6063.6 Da |
| Half-Life | n/a | About 12-24 hours |
| Amino Acids | 21 | 51 |
| Typical Dose | n/a | 0.1-0.2 U/kg once daily |
| Route | preclinical | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 13000 |
| Research Status | Pre-clinical | Approved |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Insulin Glargine Benefits
- ✓Once-daily basal coverage
- ✓Smooth action profile
- ✓Lower nocturnal hypoglycemia risk
- ✓Improves fasting glucose control
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Insulin Glargine Dosing
Inject SC once daily at the same time each day|Titrate every 3-4 days to fasting glucose targets|Can be combined with prandial insulin
Arenicin-1 Side Effects
- ⚠Arenicola marina
Insulin Glargine Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Insulin Glargine
Clinical and translational studies support its use as a basal comparator because of prolonged absorption and stable glycemic control. It is heavily used in basal-bolus regimen research and insulin-delivery optimization studies.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.